# Section 5: Regulatory Co-Development Framework

**Status**: 🔨 Active Planning
**Priority**: Critical
**Purpose**: Partnership formation for multi-stakeholder governance

---

## Core Philosophy

**TELOS is mathematical infrastructure for multi-stakeholder AI governance.**

**We provide the platform. Regulatory experts configure it.**

This is NOT about:
- ❌ Dictating what medical/financial/legal governance should be
- ❌ Claiming expertise in regulatory domains
- ❌ Building a "one-size-fits-all" solution

This IS about:
- ✅ Providing infrastructure for domain experts to configure
- ✅ Enabling multiple regulatory attractors to coexist
- ✅ Making governance observable and measurable
- ✅ Co-developing with regulators, not for them

---

## Partnership Formation Process

### Phase 1: Outreach (Q4 2025)

**Objective**: Identify regulatory partners interested in co-development

**Target Organizations**:
- **Medical**: FDA (US), EMA (EU), Health Canada
- **Financial**: SEC (US), FCA (UK), BaFin (Germany)
- **Legal**: ABA (American Bar Association), Law Society (UK)
- **Environmental**: EPA (US), European Environment Agency
- **Educational**: Department of Education, accreditation bodies

**Approach**:
1. **Initial Contact**: Email introducing TELOS platform
2. **Demo Request**: Offer February 2026 demonstration
3. **White Paper**: Share technical documentation
4. **Exploratory Call**: Discuss domain-specific needs

### Phase 2: Discovery (Q1 2026)

**Objective**: Understand domain-specific governance requirements

**Activities**:
1. **Requirements Gathering**
   - What are the critical boundaries in your domain?
   - What constitutes drift or misalignment?
   - What interventions are appropriate?

2. **Risk Assessment**
   - What are the highest-risk failure modes?
   - What are the consequences of governance failure?
   - What evidence would satisfy your oversight needs?

3. **Configuration Workshops**
   - Define governance profile (purpose, scope, boundaries)
   - Set drift thresholds
   - Design intervention strategies

### Phase 3: Joint Configuration (Q1-Q2 2026)

**Objective**: Build domain-specific attractors together

**Process**:
```
Week 1-2: Define Governance Profile
  ↓
Week 3-4: Configure Attractor Parameters
  ↓
Week 5-6: Test with Domain-Specific Messages
  ↓
Week 7-8: Iterate Based on Expert Feedback
  ↓
Week 9-10: Validation Study
  ↓
Week 11-12: Documentation and Handoff
```

**Deliverables**:
- Domain-specific governance profile (JSON)
- Validation study results
- Configuration guide
- Compliance evidence template

### Phase 4: Supervised Piloting (Q2-Q3 2026)

**Objective**: Deploy in controlled environments with expert oversight

**Deployment Models**:
1. **Internal Pilot**: Within regulatory organization
2. **Controlled Partner**: Single approved organization
3. **Sandbox Environment**: Isolated test deployment

**Monitoring**:
- Weekly reports on drift detection
- Monthly efficacy analysis (ΔF trends)
- Quarterly compliance reviews

**Feedback Loop**:
- Expert review of intervention decisions
- Adjustment of thresholds and policies
- Iterative refinement

### Phase 5: Scaling (2027+)

**Objective**: Expand to production deployments

**Prerequisites**:
- ✅ Pilot results validate efficacy
- ✅ Regulatory approval secured
- ✅ Evidence generation proven
- ✅ Performance meets requirements

---

## Target Regulatory Bodies

### Medical Governance

**Primary Partners**:
- **FDA (Food and Drug Administration)** - USA
- **EMA (European Medicines Agency)** - EU
- **Health Canada** - Canada

**Governance Focus**:
- Medical advice boundaries
- Diagnosis deferral to licensed professionals
- Emergency triage protocols
- Patient safety prioritization

**Example Governance Profile** (Illustrative Only):
```json
{
  "purpose": [
    "Provide accurate, general health information",
    "Prioritize patient safety in all interactions",
    "Defer to licensed professionals for diagnosis and treatment"
  ],
  "scope": [
    "General health education",
    "Symptom descriptions (educational only)",
    "Treatment options overview (not recommendations)"
  ],
  "boundaries": [
    "NO diagnosis without licensed physician review",
    "NO prescription recommendations",
    "NO emergency medical advice (refer to 911/emergency services)",
    "NO contradicting licensed professional guidance"
  ]
}
```

### Financial Governance

**Primary Partners**:
- **SEC (Securities and Exchange Commission)** - USA
- **FCA (Financial Conduct Authority)** - UK
- **BaFin (Federal Financial Supervisory Authority)** - Germany

**Governance Focus**:
- Investment advice boundaries
- Fiduciary duty compliance
- Risk disclosure requirements
- Personalized advice restrictions

**Example Governance Profile** (Illustrative Only):
```json
{
  "purpose": [
    "Provide general financial education",
    "Explain investment concepts and terminology",
    "Promote informed financial decision-making"
  ],
  "scope": [
    "Personal finance basics",
    "Investment terminology and concepts",
    "Risk management principles",
    "Market mechanics (educational)"
  ],
  "boundaries": [
    "NO specific investment recommendations without licensed advisor",
    "NO personalized financial advice",
    "NO guarantees or predictions of returns",
    "NO tax advice without qualified professional"
  ]
}
```

### Legal Governance

**Primary Partners**:
- **ABA (American Bar Association)** - USA
- **Law Society** - UK
- **Canadian Bar Association** - Canada

**Governance Focus**:
- Legal advice boundaries
- Attorney-client privilege protection
- Jurisdiction-specific guidance
- Unauthorized practice prevention

**Example Governance Profile** (Illustrative Only):
```json
{
  "purpose": [
    "Provide general legal information",
    "Explain legal concepts and processes",
    "Direct users to appropriate legal resources"
  ],
  "scope": [
    "Legal terminology and concepts",
    "Court processes and procedures",
    "Rights and responsibilities (general)",
    "Legal resource navigation"
  ],
  "boundaries": [
    "NO specific legal advice without licensed attorney",
    "NO representation or advocacy",
    "NO jurisdiction-specific guidance without local counsel",
    "NO creating attorney-client relationship"
  ]
}
```

---

## Configuration Methodology

### Step 1: Define Governance Profile

**Workshop Agenda** (2-day session):

**Day 1: Purpose and Scope**
- Morning: What is the purpose of AI in this domain?
- Afternoon: What topics/activities are in scope?

**Day 2: Boundaries and Thresholds**
- Morning: What are the critical boundaries?
- Afternoon: Where should drift thresholds be set?

**Deliverable**: Draft governance profile (JSON)

### Step 2: Translate to Attractor

**Technical Process**:
1. Convert profile to text corpus
2. Generate embeddings
3. Calculate centroid
4. Set basin radius based on threshold discussions
5. Validate with test messages

**Validation Questions**:
- Does high-fidelity align with expert judgment?
- Does low-fidelity correctly identify drift?
- Are edge cases handled appropriately?

### Step 3: Test and Iterate

**Testing Protocol**:
1. Create test dataset (100+ messages)
   - 30% clearly in-scope
   - 30% clearly out-of-scope
   - 40% edge cases

2. Evaluate with attractor

3. Expert review:
   - Where does attractor agree with expert?
   - Where does attractor disagree?
   - Why are there discrepancies?

4. Iterate:
   - Adjust governance profile text
   - Recalculate centroid
   - Re-test

**Success Criteria**:
- Agreement > 85%
- No critical misses (high-risk false negatives)
- Acceptable false positives (conservative is OK)

### Step 4: Deploy in Supervised Mode

**Monitoring Dashboard**:
- Live fidelity metrics
- Drift detection events
- Intervention decisions
- Expert review queue

**Expert Review Process**:
1. System flags drift (F < threshold)
2. Expert reviews message + fidelity
3. Expert confirms or overrides
4. Feedback incorporated into next iteration

---

## Supervised Piloting Approach

### Deployment Architecture

```
User Message
    ↓
TELOS Platform (Domain-Specific Attractor)
    ↓
Drift Detected? (F < threshold)
    ├─ YES → Queue for Expert Review
    │        ├─ Expert Confirms → Intervention Applied
    │        └─ Expert Overrides → Adjustment Logged
    └─ NO → Continue
    ↓
Response to User
    ↓
TELOSCOPE Evidence Generation (background)
```

### Expert Review Interface

**Daily Review Queue**:
- List of drift events (sorted by severity)
- For each event:
  - User message
  - Assistant response
  - Fidelity score
  - Drift distance
  - Proposed intervention
  - Expert decision: [Approve] [Override] [Flag for Discussion]

**Weekly Summary**:
- Total drift events
- Expert approval rate
- Common override patterns
- Suggested threshold adjustments

### Feedback Integration

**Monthly Iteration Cycle**:
1. **Week 1**: Collect expert overrides
2. **Week 2**: Analyze patterns
3. **Week 3**: Propose adjustments
4. **Week 4**: Implement and validate

**Adjustment Types**:
- Governance profile refinement
- Threshold tuning
- Basin radius modification
- Intervention strategy updates

---

## February 2026 Demo Goals

### Honest Positioning

**What We Will Demonstrate**:
- ✅ Infrastructure for multi-stakeholder governance
- ✅ Quantifiable evidence generation (ΔF metric)
- ✅ Real-time drift detection
- ✅ Counterfactual branching
- ✅ Statistical validation
- ✅ Observable governance mechanics

**What We Will NOT Claim**:
- ❌ "This is medical governance" (it's illustrative)
- ❌ "This replaces regulatory expertise" (it enables it)
- ❌ "This is ready for production" (it's ready for piloting)
- ❌ "This solves all governance problems" (it's infrastructure)

### Demo Script Outline

**Duration**: 30 minutes

#### Introduction (5 minutes)
- **Problem**: AI governance is abstract, unobservable, unprovable
- **Solution**: TELOSCOPE makes governance concrete, observable, provable
- **Positioning**: Infrastructure for regulatory experts to configure

#### Live Demo (15 minutes)

**Part 1: On-Topic Conversation (3 min)**
- Show high fidelity (F > 0.8)
- Demonstrate real-time metrics
- Explain basin membership

**Part 2: Intentional Drift (3 min)**
- Ask off-topic question
- Watch fidelity drop (F < 0.8)
- Show drift detection trigger

**Part 3: TELOSCOPE View (7 min)**
- Navigate to counterfactual evidence
- Show ΔF metric (improvement quantified)
- Display side-by-side comparison:
  - Baseline: continued drift
  - TELOS: intervention corrected
- Explain statistical significance
- Show divergence chart

**Part 4: Export Evidence (2 min)**
- Download JSON with complete audit trail
- Show format suitable for compliance

#### Multi-Attractor Preview (5 minutes)
- Demonstrate Parallel TELOS (if ready)
- Show medical + financial attractors evaluating same message
- Explain consensus mechanism
- **Emphasize**: Example attractors are illustrative only

#### Q&A and Partnership Discussion (5 minutes)
- Open floor for questions
- Discuss co-development opportunities
- Outline partnership formation process
- Provide contact information

### Target Audience

**Primary**:
- Regulatory agency staff
- Compliance officers
- Domain experts (medical, financial, legal)

**Secondary**:
- AI researchers
- Policy makers
- Industry partners

### Desired Outcomes

1. **Interest**: At least 3 regulatory bodies express interest
2. **Meetings**: Schedule follow-up discovery sessions
3. **Feedback**: Collect domain-specific requirements
4. **Partnerships**: Initiate 1-2 pilot partnerships

---

## Evidence Format for Regulators

### Compliance Export Structure

```json
{
  "experiment_id": "exp_20260215_001",
  "timestamp": "2026-02-15T14:30:00Z",
  "governance_profile": {
    "purpose": [...],
    "scope": [...],
    "boundaries": [...]
  },
  "trigger_event": {
    "turn_id": 5,
    "timestamp": "2026-02-15T14:25:00Z",
    "user_message": "...",
    "assistant_response": "...",
    "fidelity": 0.65,
    "drift_distance": 1.2,
    "in_basin": false,
    "reason": "Fidelity below threshold (0.8)"
  },
  "counterfactual_evidence": {
    "baseline_branch": {
      "description": "5 turns WITHOUT governance intervention",
      "turns": [...],
      "final_fidelity": 0.39
    },
    "telos_branch": {
      "description": "5 turns WITH governance intervention",
      "turns": [...],
      "final_fidelity": 0.91
    },
    "delta_f": 0.52,
    "improvement_percentage": 133.3
  },
  "statistical_analysis": {
    "p_value": 0.0012,
    "cohens_d": 2.3,
    "confidence_interval_95": [0.35, 0.69],
    "interpretation": "TELOS significantly improves outcomes (p < 0.05, large effect)"
  },
  "visualizations": {
    "divergence_chart_url": "...",
    "metrics_table": [...]
  },
  "compliance_metadata": {
    "session_id": "...",
    "operator": "...",
    "regulatory_domain": "healthcare",
    "review_status": "pending_expert_review"
  }
}
```

### Audit Trail Components

1. **Immutable Snapshots**: Every turn saved as frozen dataclass
2. **Complete History**: All user/assistant messages preserved
3. **Metrics Trail**: Fidelity, drift, basin status per turn
4. **Intervention Log**: All governance actions recorded
5. **Evidence Chain**: Counterfactual experiments linked to triggers

---

## Open Questions for Co-Development

**We openly acknowledge we don't know the answers to:**

1. **Medical Governance**:
   - What constitutes "medical advice" vs "health information"?
   - How should emergency situations be triaged?
   - What disclaimers are required?

2. **Financial Governance**:
   - Where is the line between education and advice?
   - How should risk be disclosed?
   - What fiduciary duties apply?

3. **Legal Governance**:
   - What creates an attorney-client relationship?
   - How to handle jurisdiction-specific law?
   - What constitutes unauthorized practice?

4. **Multi-Attractor Conflicts**:
   - If medical and financial attractors disagree, which wins?
   - How should consensus be weighted?
   - Can one domain veto another?

**Our approach**: Partner with experts who DO know the answers.

---

## Partnership Models

### Model 1: Advisory Partnership
- **Commitment**: Quarterly meetings
- **Activities**: Review governance profiles, provide feedback
- **Compensation**: Credit in publications, public acknowledgment

### Model 2: Pilot Partnership
- **Commitment**: 6-month supervised pilot
- **Activities**: Deploy in controlled environment, expert oversight
- **Compensation**: Shared IP on domain-specific configurations

### Model 3: Strategic Partnership
- **Commitment**: Long-term collaboration
- **Activities**: Joint development, co-authored publications, regulatory submissions
- **Compensation**: Revenue sharing, co-ownership of domain solutions

---

## Timeline

### Q4 2025: Outreach
- Identify target organizations
- Prepare demo materials
- Initial contact emails

### Q1 2026: Discovery
- February 2026 demo
- Follow-up meetings
- Requirements gathering

### Q2 2026: Configuration
- Joint workshops
- Attractor development
- Validation studies

### Q3 2026: Piloting
- Supervised deployments
- Expert review cycles
- Iterative refinement

### Q4 2026+: Scaling
- Production readiness
- Regulatory approval process
- Expanded deployments

---

## Success Metrics

### Partnership Formation
- Target: 3-5 regulatory partnerships by June 2026
- Target: 1-2 pilot deployments by September 2026

### Configuration Quality
- Expert agreement > 85% on test cases
- Critical miss rate < 1%
- False positive rate < 20%

### Evidence Generation
- 100% of drift events have counterfactual evidence
- Statistical significance in > 80% of experiments
- Audit trail completeness 100%

---

## Cross-Reference

**TASKS.md Section 5**: Regulatory partnership tasks
**TELOS_BUILD_MANIFEST.md**: Main navigation
**Section 3: Parallel Architecture**: Multi-attractor infrastructure

---

## Summary

**Regulatory co-development is core to TELOS.**

**Philosophy**: Infrastructure, not prescription
**Approach**: Partner with experts, don't replace them
**Timeline**: Feb 2026 demo → Q2 2026 pilots → 2027 production

**Next Step**: February 2026 demonstration and partnership outreach

🤝 **Purpose: Enable regulatory experts to configure observable, measurable AI governance**
